Spatial analysis of KS/PDX biopsies confirmed that CXCL12 was higher in tumor regions with fibroblast-clusters, while expression of CXCR4, the receptor of CXCL12 was higher in regions with KS signature clusters (Fig. 7G). The gene discussed is CXCR4; the disease is Kaposi's sarcoma.